Myeloproliferative Neoplasms
Definition
- A group of non-leukemic clonal stem cell diseases characterized by uncontrolled marrow proliferation due to tyrosine kinase activating mutations
Historical Name
- Myeloproliferative Syndromes
Diagnostic Criteria
- Select disease below for details
| Disease | Tyrosine Kinase Affected | Peripheral Blood | Marrow Cell Lines Affected | Marrow Fibrosis |
|---|---|---|---|---|
| CML | ABL | Leukocytosis with increased basophils & Igs | Markedly increased myeloids | Variable |
| Polycythemia Vera | JAK2 | Normo- or hypochromic anemia, may have increased platelets & basophils | Panmyelosis, variable erythroid hyperplasia, atypical megakaryocytes | Increased in spent phase |
| Essential Thrombocythemia | JAK2 or MPL | Platelets increased, frequently abnormal | Markedly increased megakaryocytes | Minimal |
| Primary Myelofibrosis | JAK2 or MPL | Leukoerythroblastic, teardrop RBCs | Panmyelosis, atypical megakaryocytes | Increased in fibrotic phase |
| Chronic Neutrophilic Leukemia | JAK2 rare | Increased, normal granulocytes | Granulocytic hyperplasia | None |
| Chronic Eosinophilic Leukemia, NOS | None | Eosinophilia | Eosinophilic hyperplasia with maturation | Occasional |
| Hematolymphoid Neoplasms with Eosinophilia & Specific Tyrosine Kinase Abnormalities | PDGFRA, PDGFRB, FGFR1 | Eosinophilia | Eosinophilic hyperplasia with maturation | May be increased |
| Mastocytosis | KIT | Variable | Variable | Frequent |
| Myeloproliferative Neoplasm, Unclassifiable | None | Variable | Variable | Variable |
Dita Gratzinger MD PhD
Tracy I George MD
Department of Pathology
Stanford University School of Medicine
Stanford CA 94305-5342
Original posting: 10/23/11

